Iron status
Trials find iron bisglycinate raises haemoglobin and ferritin comparably to ferrous sulfate, often at lower elemental doses and with fewer gastrointestinal complaints. The trials are smaller and fewer than those behind ferrous sulfate, which is why guidelines still name sulfate first.
Moderate evidence. Several human studies point the same way, with real caveats.
View the 4 sources
- The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials.(opens in a new tab)
Meta-analysis · Nutrition reviews · 2023 · PMID 36728680
- Low-Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies.(opens in a new tab)
Randomised controlled trial · Journal of pregnancy · 2024 · PMID 39582678
- Efficacy and Safety of Ferrous Bisglycinate and Folinic Acid in the Control of Iron Deficiency in Pregnant Women: A Randomized, Controlled Trial.(opens in a new tab)
Randomised controlled trial · Nutrients · 2022 · PMID 35276810
- Is a Lower Dose of More Bioavailable Iron (18-mg Ferrous Bisglycinate) Noninferior to 60-mg Ferrous Sulfate in Increasing Ferritin Concentrations While Reducing Gut Inflammation and Enteropathogen Detection in Cambodian Women? A Randomized Controlled Noninferiority Trial.(opens in a new tab)
Randomised controlled trial · The Journal of nutrition · 2023 · PMID 37271416
Deep research mode adds each paper’s own conclusion and stated limitations.